DURHAM, N.C.--(BUSINESS WIRE)--Xilis, Inc., a pioneering company developing its MicroOrganoSphere TM (MOS) technology to guide precision therapy for cancer patients and accelerate drug discovery and ...
The MOS Technology 6502 is a microprocessor which casts a long shadow over the world of computing. Many of you will know it as the beating heart of so many famous 8-bit machines from the likes of ...
DURHAM, N.C.--(BUSINESS WIRE)--Xilis, Inc., a pioneering company using its MicroOrganoSphere (MOS) technology to guide precision therapy for cancer patients and accelerate drug discovery and ...
The MOS Technology 6502 is a microprocessor which casts a long shadow over the world of computing. Many of you will know it as the beating heart of so many famous 8-bit machines from the likes of ...
Examining the effect of dementia on hospitalization outcome for GI cancer: A nationwide retrospective analysis. Technical performance of cancer detection and TOO identification of PanSeer7, a targeted ...
Following the closing of a $70 million series A in July 2021, Xilis—the biotechnology company behind MicroOrganoSphere (MOS) technology, which generates thousands of miniature patient-derived tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results